Covered recipient · General Payments record
MELANIE E WATKINS
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$5,519.02
- Reported across 88 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,000.00 | 8 |
| Food and Beverage | $173.54 | 8 |
| Education | $112.35 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MIMEDX Group, Inc. | $4,000.00 | 8 |
| Astellas Pharma US Inc | $118.65 | 2 |
| Novo Nordisk AS | $41.66 | 2 |
| MILLICENT US INC | $35.53 | 2 |
| Hologic Sales and Service, LLC | $31.32 | 1 |
| Exeltis, USA Inc. | $20.50 | 1 |
| BAXTER HEALTHCARE | $19.84 | 1 |
| Organon LLC | $18.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $99.00 | 09/05/2024 | Education | Undisputed | 01/23/2026 | 1139408693 | CMS |
| Astellas Pharma US Inc | $19.65 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139403829 | CMS |
| Baxter Healthcare | $19.84 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120626753 | CMS |
| Exeltis, USA Inc. | $20.50 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150007158 | CMS |
| Hologic Sales and Service, LLC | $31.32 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084877546 | CMS |
| MILLICENT US INC | $22.18 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150913157 | CMS |
| MILLICENT US INC | $13.35 | 10/30/2024 | Education | Undisputed | 01/23/2026 | 1150913159 | CMS |
| MIMEDX Group, Inc. | $1,200.00 | 04/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140271634 | CMS |
| MIMEDX Group, Inc. | $200.00 | 05/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140271636 | CMS |
| MIMEDX Group, Inc. | $400.00 | 06/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140271638 | CMS |
| MIMEDX Group, Inc. | $200.00 | 07/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140271640 | CMS |
| MIMEDX Group, Inc. | $1,000.00 | 08/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140271642 | CMS |
| MIMEDX Group, Inc. | $200.00 | 09/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140271644 | CMS |
| MIMEDX Group, Inc. | $400.00 | 10/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140271646 | CMS |
| MIMEDX Group, Inc. | $400.00 | 11/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1140271648 | CMS |
| Novo Nordisk Inc | $20.83 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096619618 | CMS |
| Novo Nordisk Inc | $20.83 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096864939 | CMS |
| Organon Llc | $18.39 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136317165 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.